REPORT ID 13797

United States Oral Anticoagulant Market Report 2017

Publish Date
22-Nov-17
Pages
97
Format
Electronic (PDF)

In this report, the United States Oral Anticoagulant market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Oral Anticoagulant in these regions, from 2012 to 2022 (forecast).

United States Oral Anticoagulant market competition by top manufacturers/players, with Oral Anticoagulant sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Akers Biosciences
    Pfizer
    Eisai
    AstraZeneca
    Eli Lilly
    Medicure
    GlaxoSmithKline
    Novartis AG
    Sanofi

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Warfarin
    Dabigatran
    Rivaroxaban
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Thromboembolic Disease
    Disseminated Intravascular Coagulation
    Cardiovascular Surgery
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Oral Anticoagulant Market Report 2017
1 Oral Anticoagulant Overview
    1.1 Product Overview and Scope of Oral Anticoagulant
    1.2 Classification of Oral Anticoagulant by Product Category
        1.2.1 United States Oral Anticoagulant Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Oral Anticoagulant Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Warfarin
        1.2.4 Dabigatran
        1.2.5 Rivaroxaban
        1.2.6 Others
    1.3 United States Oral Anticoagulant Market by Application/End Users
        1.3.1 United States Oral Anticoagulant Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Thromboembolic Disease
        1.3.3 Disseminated Intravascular Coagulation
        1.3.4 Cardiovascular Surgery
        1.3.5 Others
    1.4 United States Oral Anticoagulant Market by Region
        1.4.1 United States Oral Anticoagulant Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Oral Anticoagulant Status and Prospect (2012-2022)
        1.4.3 Southwest Oral Anticoagulant Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Oral Anticoagulant Status and Prospect (2012-2022)
        1.4.5 New England Oral Anticoagulant Status and Prospect (2012-2022)
        1.4.6 The South Oral Anticoagulant Status and Prospect (2012-2022)
        1.4.7 The Midwest Oral Anticoagulant Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Oral Anticoagulant (2012-2022)
        1.5.1 United States Oral Anticoagulant Sales and Growth Rate (2012-2022)
        1.5.2 United States Oral Anticoagulant Revenue and Growth Rate (2012-2022)

2 United States Oral Anticoagulant Market Competition by Players/Suppliers
    2.1 United States Oral Anticoagulant Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Oral Anticoagulant Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Oral Anticoagulant Average Price by Players/Suppliers (2012-2017)
    2.4 United States Oral Anticoagulant Market Competitive Situation and Trends
        2.4.1 United States Oral Anticoagulant Market Concentration Rate
        2.4.2 United States Oral Anticoagulant Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Oral Anticoagulant Manufacturing Base Distribution, Sales Area, Product Type

3 United States Oral Anticoagulant Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Oral Anticoagulant Sales and Market Share by Region (2012-2017)
    3.2 United States Oral Anticoagulant Revenue and Market Share by Region (2012-2017)
    3.3 United States Oral Anticoagulant Price by Region (2012-2017)

4 United States Oral Anticoagulant Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Oral Anticoagulant Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Oral Anticoagulant Revenue and Market Share by Type (2012-2017)
    4.3 United States Oral Anticoagulant Price by Type (2012-2017)
    4.4 United States Oral Anticoagulant Sales Growth Rate by Type (2012-2017)

5 United States Oral Anticoagulant Sales (Volume) by Application (2012-2017)
    5.1 United States Oral Anticoagulant Sales and Market Share by Application (2012-2017)
    5.2 United States Oral Anticoagulant Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Oral Anticoagulant Players/Suppliers Profiles and Sales Data
    6.1 Akers Biosciences
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Oral Anticoagulant Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Akers Biosciences Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Pfizer
        6.2.2 Oral Anticoagulant Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Pfizer Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Eisai
        6.3.2 Oral Anticoagulant Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Eisai Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 AstraZeneca
        6.4.2 Oral Anticoagulant Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 AstraZeneca Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Eli Lilly
        6.5.2 Oral Anticoagulant Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Eli Lilly Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Medicure
        6.6.2 Oral Anticoagulant Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Medicure Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 GlaxoSmithKline
        6.7.2 Oral Anticoagulant Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 GlaxoSmithKline Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Novartis AG
        6.8.2 Oral Anticoagulant Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Novartis AG Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Sanofi
        6.9.2 Oral Anticoagulant Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Sanofi Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview

7 Oral Anticoagulant Manufacturing Cost Analysis
    7.1 Oral Anticoagulant Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Oral Anticoagulant

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Oral Anticoagulant Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Oral Anticoagulant Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Oral Anticoagulant Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Oral Anticoagulant Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Oral Anticoagulant Sales Volume Forecast by Type (2017-2022)
    11.3 United States Oral Anticoagulant Sales Volume Forecast by Application (2017-2022)
    11.4 United States Oral Anticoagulant Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer